BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2095136)

  • 1. Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugs.
    Galle PR; Theilmann L
    Arzneimittelforschung; 1990 Dec; 40(12):1380-2. PubMed ID: 2095136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
    Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
    Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
    Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
    Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
    J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].
    Wu JM; Lin JS; Xie N; Jiang FC; Liang KH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):268-70. PubMed ID: 12773236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of hepatitis B viral gene expression and replication in vitro by targeted antisense oligonucleotides].
    Zhong S; Zhang D; Wen S
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):392-5, 444. PubMed ID: 7553155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
    Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
    J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of Chinese herb Phyllanthus on hepatitis B virus in vitro].
    Liu Z; Fu X; Zhang N; Zhang G; Liu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):282-5. PubMed ID: 15617349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
    Cao H; Tao P
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(16):1004-7. PubMed ID: 11718074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
    Delaney WE; Isom HC
    Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.